The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism

• Björn D. Kuhl,

  Current address: Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America

  Affiliations McGill University AIDS Center, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada, Department of Experimental Medicine, McGill University, Montréal, Canada

  ⨯
• Vicky Cheng,

  Affiliations McGill University AIDS Center, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada, Department of Experimental Medicine, McGill University, Montréal, Canada

  ⨯
• Daniel A. Donahue,

  Affiliations McGill University AIDS Center, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada, Department of Microbiology and Immunology, McGill University, Montréal, Canada

  ⨯
• Richard D. Sloan,

  Affiliation McGill University AIDS Center, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada

  ⨯
• Chen Liang,

  Affiliations McGill University AIDS Center, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada, Department of Experimental Medicine, McGill University, Montréal, Canada, Department of Microbiology and Immunology, McGill University, Montréal, Canada

  ⨯
• John Wilkinson,

  Affiliation Biotron Limited, St Vincent's Centre for Applied Medical Research, Sydney, Australia

  ⨯
• Mark A. Wainberg

  * E-mail: mark.wainberg@mcgill.ca

  Affiliations McGill University AIDS Center, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada, Department of Experimental Medicine, McGill University, Montréal, Canada, Department of Microbiology and Immunology, McGill University, Montréal, Canada

  ⨯